Yes, GLP-1 medications like semaglutide are FDA-approved for weight loss in individuals without diabetes but with obesity or weight-related health conditions
It is unknown whether OZEMPIC causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid Ccell tumors has not been determined
Initial Consultation $200 Comprehensive evaluation Medical history and goals review Personalized treatment plan Ongoing Care Options Membership (Most Popular) $125/month Includes: Follow-up visits and progress tracking Medication adjustments and dose optimization Ongoing medical guidance and support Direct access to your clinician for questions Pay-Per-Visit (No Membership) Follow-up visits: $150$175 per visit Best for occasional care, but most patients choose membership for ongoing support and cost savings
11 Exon 4 encodes GLP-1
Campbell in Nutrition Reviews shows that calorie restriction can lead to reductions in lean body mass unless sufficient protein intake and resistance training are maintained
For this reason, Taylor Bariatric Institute does not use compounded versions of semaglutide, tirzepatide, or related agents